Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/ß-TCP): an alternative to autogenous bone graft.

Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/ß-TCP): an alternative to autogenous bone graft. J Bone Joint Surg Am. 2013 Jul 03; 95(13):1184-92.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.